Related by context. Frequent words. (Click for all words.) 70 MultiCell Technologies 70 oncolytic virus therapies 69 Therapeutic Competitors Report 68 Mark A. Sirgo 68 www.vivus.com 68 Agios Pharmaceuticals 68 Emisphere Technologies 68 Initiates Phase II 67 Quark Pharmaceuticals 67 Inc. OTCBB BMSN 67 Regado Biosciences 67 Therapeutic Competitors 67 Genaera Corporation 67 David Aviezer 67 Active Biotech AB 67 ImmunoCellular Therapeutics 67 Genocea Biosciences 67 Inc Therapeutic Competitors 67 Diatos 67 Hyperion Therapeutics 67 MorphoSys AG FSE MOR 67 Crucell NV NYSE Euronext 66 Inovio Pharmaceuticals 66 Sachiko Kuno Ph.D. 66 Idera Pharmaceuticals 66 PRAECIS PHARMACEUTICALS INCORPORATED 66 Exploit collaboration 66 StromaCel Inc. 66 Receptos 66 Barrier Therapeutics Inc. 66 AviaraDx 66 Nautilus Biotech 66 Bayhill Therapeutics 66 PROLOR Biotech Inc. 66 * Azixa 66 Metabasis Therapeutics 66 AXYS Design Automation 66 A. Pontius 66 Sol J. Barer 65 Nasdaq CRXL 65 Completes Patient Enrollment 65 www.aveopharma.com 65 NovaBay Pharmaceuticals 65 David H. Fater 65 China Aoxing Pharmaceutical 65 Senetek PLC 65 MKC# MT 65 Receives Orphan Drug Designation 65 Cell Sci 65 MOLOGEN AG 65 Barry D. Quart 65 NASDAQ CRXL 65 Juergen Engel Ph.D. 65 Nutra Pharma Corporation 65 ® bortezomib 65 invivodata inc 65 By Neil Osterweil 65 Regulatory Disclosure 65 Commences Phase 65 www.spectrumpharm.com 64 Addrenex Pharmaceuticals 64 fibrosis IPF 64 www.syntapharma.com 64 www.quintiles.com 64 HAWTHORNE Calif. BUSINESS WIRE 64 Nutrastar International 64 Sunesis Pharmaceuticals 64 EyeGate Pharma 64 Chemokine Therapeutics 64 Peptimmune 64 Taiho Pharmaceutical 64 Morgan J. Poliquin 64 www.epixpharma.com 64 Geekzone ® SohoSolutions 64 API Nanotronics 64 Cerus Corporation 64 ImmuneRegen BioSciences Inc. 64 Crucell NV Euronext 64 Biotest AG 64 Akesis Pharmaceuticals 64 immatics 64 Urigen Pharmaceuticals Inc. 64 MacuSight 64 Presents Positive 64 Pyng Medical 64 Intarcia 64 Millennium Biotechnologies 64 By Rick Nauert 64 IRIDEX Corporation 64 Salmedix 64 Avila Therapeutics 64 TaiGen 64 Meets Primary Endpoint 64 Æterna Zentaris Inc. 64 CONMED Corporation 64 Acologix 64 professionals technological obsolescence 64 Callisto Pharmaceuticals Inc. 64 Pressure BioSciences 63 Halozyme Therapeutics 63 Inc. Nasdaq IMGN